Skip to content

Homoeopathic medicine in essential hypertension

To evaluate the effectiveness of Homoeopathic Mother tincture Sarothamnus scoparius in managing essential hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036584
Enrollment
30
Registered
2021-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Sarothamnus scoparius Q: 10 drops twice in a day with water for one week followed by Plcebo... Control Intervention1: NIL: NIL

Sponsors

Dr Vivek kmuar shail
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age in between 20 to 70 years 2) Newly diagnosed or subjects with Pre-hypertension (diastolic BP [DBP] 80-89 mmHg and systolic BP [SBP] 120-139 mmHg) of less than one year duration. 3) Patients with stage 1 (SBP >140 and 90 and 4) Written informed consent for the use of the study drugs as stand-alone treatment

Exclusion criteria

Exclusion criteria: 1) Known case of Secondary Hypertension 2) Pregnant & lactating Mother 3) Those subject have BMI >35kg-sqm 4) Patient having diabetes, cardiovascular disease 5) Cases with gross pathological changes 6) Patient with vital organ failure 7) Patient who do not give consent for participation

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of Homoeopathic Mother tincture Sarothamnus scoparius in the management of essential hypertensionTimepoint: 12 month

Secondary

MeasureTime frame
To asses the efficacy of Sarothamnus scoparius in improving Quality of Life (QOL) in hypertensive subjectsTimepoint: 12 month

Countries

India

Contacts

Public ContactDR KANAK KUMAR

R.B.T.S. Govt.Homoeopathic Medical college and Hospital

drkanak92@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026